isomethyleugenol has been researched along with Acute Promyelocytic Leukemia in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.33) | 18.7374 |
| 1990's | 11 (36.67) | 18.2507 |
| 2000's | 8 (26.67) | 29.6817 |
| 2010's | 9 (30.00) | 24.3611 |
| 2020's | 1 (3.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Gao, C; Gao, Y; Guo, M; Guo, S; Hai, X; Lin, L; Wang, X; Wu, Z | 1 |
| Gao, HY; He, XW; Shi, X; Yan, W; Yang, W | 1 |
| Liu, Z; Sun, G; Wang, F; Wang, H; Wang, Y; Xi, S; Xu, Y; Yang, Y; Zheng, Q; Zheng, Y | 1 |
| Doi, H; Ishii, H; Koyama, H; Sumi, K; Suzuki, M; Takashima-Hirano, M; Watanabe, C | 1 |
| Bu, N; Cao, FL; Naranmandura, H; Wang, QQ; Zhang, YF; Zhou, J; Zhou, XY | 1 |
| Bonaldi, T; Minucci, S; Noberini, R; Pruneri, G; Uggetti, A | 1 |
| Beekman, R; Beverloo, HB; Palande, KK; Touw, IP; Valk, PJ; van der Meeren, LE | 1 |
| Benoukraf, T; Bertucci, F; Calmels, B; Duprez, E; Ferrier, P; Grimwade, D; Mills, K; Saurin, AJ; Sieweke, M; Spicuglia, S; Tibéri, G; Vincent-Fabert, C; Zacarias-Cabeza, J | 1 |
| Borutinskaite, VV; Navakauskiene, R; Savickiene, J; Treigyte, G | 1 |
| Cao, F; Chen, B; Le, XC; Lu, X; Shen, S; Yuan, C; Zhou, J | 1 |
| Chen, GQ; Chen, Z; Jing, Y; Styblo, M; Walton, F; Waxman, S; Weinberg, R; Zhou, L | 1 |
| Gong, Z; Le, XC; Lu, X; Wang, Z; Zhou, J | 1 |
| Au, WY; Chan, CH; Chim, CS; Fung, AT; Kwong, YL; Liang, RH; Ma, ES; Wong, KF | 1 |
| Himeno, S; Kojima, C; Qu, W; Sakurai, T; Waalkes, MP | 1 |
| Botrugno, OA; Carbone, R; Di Croce, L; Insinga, A; Minucci, S; Pelicci, PG; Ronzoni, S | 1 |
| Chan, WW; Chim, CS; Kwong, YL; Pang, A | 1 |
| Fukai, Y; Hirata, M; Ichikawa, N; Kaise, T; Kinoshita, K; Kobayashi, H; Ohta, S; Saitoh, H; Sakurai, T; Ueno, M | 1 |
| He, ZX; Rao, H | 1 |
| Feldhoff, PW; Harker, WG; Holguin, MH; Parr, RL; Slade, DL; Sullivan, DM | 1 |
| Alimena, G; Arcese, W; Avvisati, G; D'Adamo, F; De Felice, L; Diverio, D; Lo Coco, F; Meloni, G; Montefusco, E; Pelicci, PG | 1 |
| Samid, D | 1 |
| Chakraborty, S; Nucifora, G; Senyuk, V | 1 |
| Chang, ZF; Cheng, SM | 1 |
| Ganser, A; Herrmann, F; Lübbert, M; Ludwig, WD; Mertelsmann, R; Oster, W | 1 |
| Humphries, DE; Nicodemus, CF; Schiller, V; Stevens, RL | 1 |
| Koeffler, HP; Lübbert, M; Miller, CW | 1 |
| Koeffler, HP; Lübbert, M; Miller, CW; Prokocimer, M; Salser, W; Thomason, A | 1 |
| Vilpo, JA; Vilpo, LM | 1 |
| Aarbakke, J; Prytz, PS | 1 |
| Hashimoto, Y; Himi, T; Kagechika, H; Kawachi, E; Shudo, K | 1 |
1 review(s) available for isomethyleugenol and Acute Promyelocytic Leukemia
| Article | Year |
|---|---|
Genetic lesions and perturbation of chromatin architecture: a road to cell transformation.
Topics: Acetylation; Amino Acid Motifs; Animals; Cell Transformation, Neoplastic; Chromatin; Chromosome Aberrations; CREB-Binding Protein; Dimerization; Gene Expression Regulation; Gene Targeting; Histones; Humans; Leukemia, Promyelocytic, Acute; Macromolecular Substances; Methylation; Mice; Models, Genetic; Multigene Family; Neoplasm Proteins; Nuclear Proteins; Nuclear Receptor Coactivator 2; Nucleosomes; Oncogene Proteins, Fusion; Phosphorylation; Protein Processing, Post-Translational; Receptors, Retinoic Acid; Trans-Activators; Transcription Factors; Transcription, Genetic; Translocation, Genetic | 2001 |
1 trial(s) available for isomethyleugenol and Acute Promyelocytic Leukemia
| Article | Year |
|---|---|
Arsenic speciation in urine from acute promyelocytic leukemia patients undergoing arsenic trioxide treatment.
Topics: Adult; Antineoplastic Agents; Arsenic; Arsenic Trioxide; Arsenicals; Arsenites; Cacodylic Acid; Chromatography, High Pressure Liquid; Humans; Injections, Intravenous; Leukemia, Promyelocytic, Acute; Male; Methylation; Middle Aged; Oxidation-Reduction; Oxides | 2004 |
28 other study(ies) available for isomethyleugenol and Acute Promyelocytic Leukemia
| Article | Year |
|---|---|
Monomethylated arsenic was the Major methylated arsenic in Red blood cells of acute promyelocytic leukemia patients treated with arsenic trioxide.
Topics: Adolescent; Adult; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Biotransformation; Cacodylic Acid; Child; Child, Preschool; Chromatography, High Pressure Liquid; Erythrocytes; Female; Hemoglobins; Humans; Infant; Infant, Newborn; Leukemia, Promyelocytic, Acute; Male; Methylation; Middle Aged; Protein Binding; Spectrometry, Fluorescence; Spectrophotometry, Atomic; Young Adult | 2021 |
[Effects of EGCG on Proliferation, Cell Cycle and DAPK1 Gene Methylation of Acute Promyelocytic Leukemia NB4 Cell Line].
Topics: Catechin; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Death-Associated Protein Kinases; Humans; Leukemia, Promyelocytic, Acute; Methylation | 2018 |
Arsenic methylation metabolism and liver injury of acute promyelocytic leukemia patients undergoing arsenic trioxide treatment.
Topics: Adolescent; Adult; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Female; Humans; Leukemia, Promyelocytic, Acute; Leukocytosis; Liver; Liver Function Tests; Male; Methylation; Middle Aged; Oxides; Sex Factors; Young Adult | 2013 |
Synthesis of (11)C-labeled retinoic acid, [(11)C]ATRA, via an alkenylboron precursor by Pd(0)-mediated rapid C-[(11)C]methylation.
Topics: Alkenes; Antineoplastic Agents; Boron Compounds; Carbon Isotopes; Catalysis; Contrast Media; Humans; Leukemia, Promyelocytic, Acute; Methylation; Palladium; Positron-Emission Tomography; Tretinoin | 2014 |
Methylated arsenic metabolites bind to PML protein but do not induce cellular differentiation and PML-RARα protein degradation.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Biotransformation; Cacodylic Acid; Cell Differentiation; Cell Proliferation; Dose-Response Relationship, Drug; HEK293 Cells; HeLa Cells; Humans; Leukemia, Promyelocytic, Acute; Methylation; Nuclear Proteins; Oncogene Proteins, Fusion; Organometallic Compounds; Oxides; Promyelocytic Leukemia Protein; Proteasome Endopeptidase Complex; Protein Binding; Protein Interaction Domains and Motifs; Proteolysis; Sumoylation; Time Factors; Transcription Factors; Tumor Suppressor Proteins | 2015 |
Pathology Tissue-quantitative Mass Spectrometry Analysis to Profile Histone Post-translational Modification Patterns in Patient Samples.
Topics: Animals; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Line, Tumor; Female; Histones; Humans; Leukemia, Promyelocytic, Acute; Methylation; Mice; Protein Processing, Post-Translational; Proteomics; Tandem Mass Spectrometry; Tissue Fixation | 2016 |
The antioxidant protein peroxiredoxin 4 is epigenetically down regulated in acute promyelocytic leukemia.
Topics: Antioxidants; Down-Regulation; Epigenesis, Genetic; Granulocyte Colony-Stimulating Factor; Histones; Humans; Leukemia, Promyelocytic, Acute; Lysine; Methylation; Peroxiredoxins; Transcription Initiation Site | 2011 |
Characterisation of genome-wide PLZF/RARA target genes.
Topics: Acetylation; Binding Sites; Chromatin Immunoprecipitation; Cluster Analysis; Gene Expression Profiling; Gene Expression Regulation, Leukemic; Genome-Wide Association Study; Histones; Humans; Kruppel-Like Transcription Factors; Leukemia, Promyelocytic, Acute; Methylation; Oligonucleotide Array Sequence Analysis; Oncogene Proteins, Fusion; Promoter Regions, Genetic; Promyelocytic Leukemia Zinc Finger Protein; Protein Binding; Reverse Transcriptase Polymerase Chain Reaction; Transcription Factors; U937 Cells | 2011 |
Antileukemic activity of combined epigenetic agents, DNMT inhibitors zebularine and RG108 with HDAC inhibitors, against promyelocytic leukemia HL-60 cells.
Topics: Acetylation; Cadherins; CD11b Antigen; Cell Differentiation; Cell Proliferation; CpG Islands; Cytidine; Enzyme Inhibitors; Epigenesis, Genetic; Histone Deacetylase Inhibitors; Histones; HL-60 Cells; Humans; Indoles; Leukemia, Promyelocytic, Acute; Methylation; Phthalimides; Promoter Regions, Genetic; Propionates; Tretinoin; Tryptophan | 2012 |
Arsenic speciation in saliva of acute promyelocytic leukemia patients undergoing arsenic trioxide treatment.
Topics: Adult; Antineoplastic Agents; Arsenates; Arsenic Trioxide; Arsenicals; Arsenites; Cacodylic Acid; Chromatography, High Pressure Liquid; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Leukemia, Promyelocytic, Acute; Male; Methylation; Middle Aged; Oxides; Saliva; Spectrophotometry, Atomic | 2013 |
Methylated metabolites of arsenic trioxide are more potent than arsenic trioxide as apoptotic but not differentiation inducers in leukemia and lymphoma cells.
Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Differentiation; Coculture Techniques; Glutathione Peroxidase; Hematopoietic Stem Cells; Humans; Hydrogen Peroxide; K562 Cells; Leukemia, Promyelocytic, Acute; Liver Neoplasms; Lymphoma; Methylation; Neoplasm Proteins; Oncogene Proteins, Fusion; Oxides; Tumor Cells, Cultured | 2003 |
Serial studies of methylation of CDKN2B and CDKN2A in relapsed acute promyelocytic leukaemia treated with arsenic trioxide.
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Case-Control Studies; Cyclin-Dependent Kinase Inhibitor p15; Cyclin-Dependent Kinase Inhibitor p16; Humans; Leukemia, Promyelocytic, Acute; Methylation; Neoplasm, Residual; Oxides; Reverse Transcriptase Polymerase Chain Reaction | 2005 |
Chronic exposure to methylated arsenicals stimulates arsenic excretion pathways and induces arsenic tolerance in rat liver cells.
Topics: Animals; Arsenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Glutathione Transferase; Leukemia, Promyelocytic, Acute; Liver; Methylation; Rats; Rats, Inbred F344 | 2006 |
Recruitment of the histone methyltransferase SUV39H1 and its role in the oncogenic properties of the leukemia-associated PML-retinoic acid receptor fusion protein.
Topics: Cell Differentiation; DNA Methylation; Gene Silencing; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Histones; Humans; Leukemia, Promyelocytic, Acute; Methylation; Methyltransferases; Models, Biological; Neoplasm Proteins; Nuclear Proteins; Oncogene Proteins, Fusion; Promyelocytic Leukemia Protein; Protein Methyltransferases; Repressor Proteins; Transcription Factors; Transcription, Genetic; Transfection; Tumor Suppressor Proteins; U937 Cells | 2006 |
Preferential methylation of Wnt inhibitory factor-1 in acute promyelocytic leukemia: an independent poor prognostic factor.
Topics: Adaptor Proteins, Signal Transducing; Azacitidine; Biomarkers, Tumor; Carrier Proteins; Cell Line, Tumor; Cell Proliferation; Humans; Leukemia, Promyelocytic, Acute; Methylation; Multivariate Analysis; Prognosis; Recurrence; Remission Induction; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Risk Factors; RNA, Messenger; Sensitivity and Specificity; Survival Rate; Tretinoin; Tumor Cells, Cultured | 2006 |
Clinical pharmacokinetic study of arsenic trioxide in an acute promyelocytic leukemia (APL) patient: speciation of arsenic metabolites in serum and urine.
Topics: Aged; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Chromatography, High Pressure Liquid; Drug Resistance, Neoplasm; Humans; Injections, Intravenous; Leukemia, Promyelocytic, Acute; Male; Methylation; Oxides; Seafood; Tretinoin | 2006 |
The effect of 5-azacytidine (5-aza-CR) and its analogue on cell differentiation and DNA methylation of HL-60 cells.
Topics: Antineoplastic Agents; Azacitidine; Cell Differentiation; Decitabine; DNA-Cytosine Methylases; DNA-Directed RNA Polymerases; DNA, Neoplasm; Humans; Leukemia, Promyelocytic, Acute; Methylation; Tumor Cells, Cultured | 1993 |
Alterations in the topoisomerase II alpha gene, messenger RNA, and subcellular protein distribution as well as reduced expression of the DNA topoisomerase II beta enzyme in a mitoxantrone-resistant HL-60 human leukemia cell line.
Topics: Base Sequence; Cell Line; DNA Primers; DNA Topoisomerases, Type II; DNA, Neoplasm; Drug Resistance; Gene Expression; Humans; Isoenzymes; Kinetics; Leukemia, Promyelocytic, Acute; Methylation; Mitoxantrone; Molecular Sequence Data; Molecular Weight; Polymerase Chain Reaction; Restriction Mapping; RNA, Messenger; Subcellular Fractions; Transcription, Genetic; Tumor Cells, Cultured | 1995 |
Polyclonal hematopoietic reconstitution in leukemia patients at remission after suppression of specific gene rearrangements.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bone Marrow Transplantation; Carrier Proteins; Child, Preschool; Combined Modality Therapy; DNA, Neoplasm; Female; Gene Rearrangement; Hematopoiesis; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Promyelocytic, Acute; Methylation; Middle Aged; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Receptors, Retinoic Acid; Remission Induction | 1993 |
Re: Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase.
Topics: Antineoplastic Agents; DNA, Neoplasm; Drug Synergism; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Leukemia, Promyelocytic, Acute; Methylation; Neovascularization, Pathologic; Phenylbutyrates; Transcription, Genetic; Tretinoin | 1999 |
Methylation-sensitive protein-DNA interaction at the cell cycle regulatory domain of human thymidine kinase promoter.
Topics: Base Sequence; Binding Sites; Blotting, Northern; Cell Cycle; Cell Line; Cell Nucleus; DNA, Neoplasm; HeLa Cells; Humans; Leukemia, Promyelocytic, Acute; Methylation; Molecular Sequence Data; Nuclear Proteins; Poly A; Promoter Regions, Genetic; Regulatory Sequences, Nucleic Acid; RNA; RNA, Messenger; Thymidine Kinase; Tumor Cells, Cultured | 1992 |
A switch toward demethylation is associated with the expression of myeloperoxidase in acute myeloblastic and promyelocytic leukemias.
Topics: Blotting, Northern; Blotting, Southern; DNA Probes; DNA, Neoplasm; Gene Expression; Humans; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Methylation; Peroxidase; RNA, Messenger; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1992 |
The human serglycin gene. Nucleotide sequence and methylation pattern in human promyelocytic leukemia HL-60 cells and T-lymphoblast Molt-4 cells.
Topics: Base Sequence; Blotting, Northern; Blotting, Southern; Cell Line; DNA; Humans; Introns; Leukemia, Promyelocytic, Acute; Methylation; Molecular Sequence Data; Proteoglycans; RNA; T-Lymphocytes; Tumor Cells, Cultured; Vesicular Transport Proteins | 1992 |
Changes of DNA methylation and chromatin structure in the human myeloperoxidase gene during myeloid differentiation.
Topics: Base Sequence; Bone Marrow; Bone Marrow Cells; Cell Differentiation; Cell Line; Chromatin; Cloning, Molecular; DNA; DNA, Neoplasm; Genes; Hematopoietic Stem Cells; Humans; Leukemia; Leukemia, Promyelocytic, Acute; Lymphoma; Methylation; Peroxidase; Restriction Mapping | 1991 |
Stable methylation patterns of MYC and other genes regulated during terminal myeloid differentiation.
Topics: Blotting, Northern; Blotting, Southern; Cell Differentiation; Cell Line; Chromosome Mapping; DNA; DNA Restriction Enzymes; Ferritins; Gene Expression Regulation, Leukemic; Genes, myc; Humans; Leukemia, Promyelocytic, Acute; Methylation; RNA, Messenger; RNA, Neoplasm | 1991 |
Biochemical mechanisms by which reutilization of DNA 5-methylcytosine is prevented in human cells.
Topics: 5-Methylcytosine; Cell Extracts; Cells, Cultured; Chromatography, Thin Layer; Cytosine; DCMP Deaminase; Deoxycytidine Monophosphate; DNA; Humans; Kinetics; Leukemia, Promyelocytic, Acute; Lymphocytes; Methylation; Nucleoside-Phosphate Kinase; Phosphorylation; Tetrahydrouridine; Tumor Cells, Cultured | 1991 |
Differential cell cycle perturbation by transmethylation inhibitors.
Topics: Adenosine; Adenosylhomocysteinase; Aminoglycosides; Anti-Bacterial Agents; Cell Cycle; Enzyme Inhibitors; Flow Cytometry; Humans; Hydrolases; Interphase; Kinetics; Leukemia, Promyelocytic, Acute; Methylation; Mitosis; Tubercidin; Tumor Cells, Cultured | 1990 |
Retinobenzoic acids. 1. Structure-activity relationships of aromatic amides with retinoidal activity.
Topics: Amides; Binding Sites; Cell Differentiation; Humans; Leukemia, Promyelocytic, Acute; Methylation; Molecular Structure; Retinoids; Structure-Activity Relationship | 1988 |